Rheumatology faculty photo US News and World Report banner

Rheumatology & Immunology

US News and World Report LogoThe MUSC Division of Rheumatology and Immunology is nationally recognized for excellence in patient care, innovative research, and outstanding training focused on the pathogenesis of autoimmune diseases. In 2019, the MUSC Health Rheumatology team was ranked 13th in the U.S. News & World Report list of best rheumatology programs, placing it in the top 1% of programs nationwide. 


The Division is proud to be training the next generation of physicians and investigators who will study and care for patients who suffer from rheumatic diseases. Faculty members actively participate in educating medical and graduate students, residents, clinical fellows, and postdoctoral research fellows.  Under the leadership of Faye Hant, D.O., the Rheumatology Fellowship Training Program is fully accredited and comprised of six clinical and research fellows selected from a competitive pool of candidates. Fellows are supported in part by a NIH Training Grant (Gary Gilkeson, M.D., PI). The Rheumatology Fellowship Training Program offers fellows the opportunity to see a wide array of rheumatic disease patients in a variety of clinical settings, to participate in clinical and basic research, and to obtain advanced training leading to a Master’s Degree in Clinical Research.


The Division is engaged in both clinical and basic research. Members of the Division receive funding from the American College of Rheumatology, Arthritis Foundation, Lupus Foundation, and Lupus Clinic Trials Consortium. Division faculty authored more than 50 articles/abstracts last year, including papers in leading medical and scientific journals, e.g., Journal of Biological Chemistry, Arthritis & Rheumatism, and the Journal of Rheumatology. Faculty members serve on numerous federal and private scientific review committees, editorial boards, and as officers of state and national organizations. 

Patient Care

The Division has a long tradition of providing outstanding care to patients of all ages who suffer from rheumatic diseases. In August 2018, MUSC Health was once again rated as high-performing in rheumatology by U.S. News & World Report, meaning that it ranks among the top 10 percent of hospitals in the nation for complex-care in that specialty.

The Division has earned an international reputation for its care and research relating to two autoimmune connective tissue diseases - scleroderma and lupus. Most recently, the Division was approved for the creation of the MUSC Inflammation and Fibrosis Research Center of Economic Excellence through the SmartState® SC Centers of Economic Excellence Program which focuses on clinical and translational research related to both scleroderma and lupus.

Under New Leadership

Jim Oates

New director of Division of Rheumatology and Immunology continues a strong research and clinical care legacy